Results 241 to 250 of about 187,246 (326)

Progress in vaccination against cancer (PIVAC) 2002 [PDF]

, 2005
Li, G, Rees, RC
core   +1 more source

The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

Dermatologia clinica, 2015
N. Spaccarelli, A. Rook
semanticscholar   +1 more source

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

MedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi, Izuchukwu F. Okpalanwaka, Adenike Oyegbesan, Ebenezar Okoyeocha, Mariam Oladejo, Sikiru O. Imodoye   +5 more
wiley   +1 more source

A Piercing Scar Over the Nose: A Rare Case of Cutaneous Pseudolymphoma. [PDF]

Cureus
Wadhwa S, Gupta S, Dabhra A.
europepmc   +1 more source

Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma.

Dermatologia clinica, 2015
M. Duvic
semanticscholar   +1 more source

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun, Dan Huang, Huiling Zhang, Mingyuan Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li, Zhaogang Yang   +10 more
wiley   +1 more source

From Morphology to Gene Expression Profiling in Mycosis Fungoides: Is It Still a Diagnostic Challenge? [PDF]

Diagnostics (Basel)
Filosa A, Cazzato G, Bartoli E, Antaldi E, Giantomassi F, Santoni M, Goteri G.   +6 more
europepmc   +1 more source

Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.

Journal of Investigative Dermatology, 2014
Xuesong Wu, B. Schulte, Youwen Zhou, Dipica Haribhai, A. Mackinnon, J. Plaza, C. Williams, S. Hwang   +7 more
semanticscholar   +1 more source

Collisional variant of CD8+ mycosis fungoides and indolent CD8+ lymphoid proliferation

JAAD Case Reports, 2020
Adriana Lopez, MD, Megan H. Trager, BA, Cynthia Magro, MD, Larisa J. Geskin, MD   +3 more
doaj  

Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database. [PDF]

Oncologist
Miyata K, Izawa-Ishizawa Y, Niimura T, Yoshioka T, Hyodo M, Itokazu S, Miyata T, Aizawa F, Yagi K, Kawada K, Hamano H, Zamami Y, Goda M, Ishizawa K.   +13 more
europepmc   +1 more source